These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8603347

  • 1. Translocation (12;15)(p13;q13) in a patient with relapsed acute myeloid leukemia.
    Lim SW, Falk RE, Look RM, Fuerst MM, Lawrence GN, Kusuanco DA, Giles FJ.
    Cancer Genet Cytogenet; 1996 Feb; 86(2):165-7. PubMed ID: 8603347
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA, Czepulkowski B, Ireland R.
    Leuk Res; 1996 Feb; 20(11-12):987-8. PubMed ID: 9009258
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).
    Corral Mdel P, Villa O, Alfaro EM, Alonso CN, Baro C, Felice MS, Rossi J, Solé F, Gallego MS.
    Pediatr Blood Cancer; 2008 Mar; 50(3):651-4. PubMed ID: 17405156
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.
    Liu H, Fu R, Li L, Wang G, Song J, Ruan E, Wang H, Wu Y, Wang X, Ding K, Shao Z.
    Clin Drug Investig; 2017 Feb; 37(2):167-174. PubMed ID: 27722823
    [Abstract] [Full Text] [Related]

  • 10. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S, Togawa J, Tanaka M, Koharazawa H, Aoba M, Fujita H, Murata T, Kanamori H, Matsuzaki M, Mohri H, Ishigatsubo Y.
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.
    Shi P, Zha J, Guo X, Chen F, Fan Z, Huang F, Meng F, Liu X, Feng R, Xu B.
    Pharmacogenomics; 2013 Jan; 14(1):17-23. PubMed ID: 23252945
    [Abstract] [Full Text] [Related]

  • 13. Translocation (2;3)(p13;q26) in two cases of myeloid malignancies. Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia.
    Fleischman EW, Volkova MA, Frenkel MA, Konstantinova LN, Kulagina OE, Baranov AE, Gordeeva AA.
    Cancer Genet Cytogenet; 1996 Apr; 87(2):182-4. PubMed ID: 8625269
    [Abstract] [Full Text] [Related]

  • 14. Acute myeloblastic leukemia (M0) with an unusual chromosomal abnormality: translocation (1;14)(p13;q32).
    Tecimer C, Loy BA, Martin AW.
    Cancer Genet Cytogenet; 1999 Jun; 111(2):175-7. PubMed ID: 10347560
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute myeloid leukemia with a severe coagulopathy and t(8;16)(p11;p13).
    Hastings A, Apperley JF, Nadal-Melsio E, Brown L, Bain BJ.
    Am J Hematol; 2021 Jan; 96(1):163-164. PubMed ID: 32520413
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T, Hiddemann W, Berdel WE, Wörmann B, Schoch C, Fonatsch C, Löffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Aul C, Gruneisen A, Lengfelder E, Frickhofen N, Kern W, Serve HL, Mesters RM, Sauerland MC, Heinecke A, German AML Cooperative Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4496-504. PubMed ID: 14673036
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.